Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

The evolution of CLL treatment

Prof Clemens Wendtner, Dr Francesc Bosch, Prof Paolo Ghia and Prof Florence Cymbalista
The evolution of CLL treatment ( Prof Clemens Wendtner, Dr Francesc Bosch,  Prof Paolo Ghia and Prof Florence Cymbalista )
28 Apr 2015

New T cell–based immunotherapy shows promise for lethal stem cell transplant complication

Dr Richard O'Reilly - Memorial Sloan Kettering Cancer Center, New York, USA
New T cell–based immunotherapy shows promise for lethal stem cell transplant complication ( Dr Richard O'Reilly - Memorial Sloan Kettering Cancer Center, New York, USA )
27 Apr 2015

DNA repair inhibitors to overcome drug resistance

Dr Ruth Plummer - Newcastle University, Newcastle, UK
DNA repair inhibitors to overcome drug resistance ( Dr Ruth Plummer - Newcastle University, Newcastle, UK )
11 Mar 2015

Putting adoptive T cell therapy on the path to regulatory approval

Prof Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA
Putting adoptive T cell therapy on the path to regulatory approval ( Prof Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA )
10 Mar 2015

New drugs and targets in haematological malignancies

Dr Renier Brentjens - Memorial Sloan Kettering Cancer Center, New York, USA
New drugs and targets in haematological malignancies ( Dr Renier Brentjens - Memorial Sloan Kettering Cancer Center, New York, USA )
10 Mar 2015

ecancermedicalscience editor's choice for February 2015

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for February 2015 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
3 Mar 2015

ASCO GU 2015 news roundup

Peter Goodwin - ecancer correspondent, London, UK
ASCO GU 2015 news roundup ( Peter Goodwin - ecancer correspondent, London, UK )
28 Feb 2015

Efficacy, tolerability and quality of life in metastatic renal cell carcinoma: Welcome and introduction

Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France
Efficacy, tolerability and quality of life in metastatic renal cell carcinoma: Welcome and introduction ( Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France )
11 Feb 2015

mRCC: Are we doing all we can to manage adverse events?

Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France
mRCC: Are we doing all we can to manage adverse events? ( Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France )
11 Feb 2015

mRCC: Real-world experience: achieving efficacy beyond clinical trials

Dr Nizar Tannir - University of Texas M.D. Anderson Cancer Center, Houston, USA
mRCC: Real-world experience: achieving efficacy beyond clinical trials ( Dr Nizar Tannir - University of Texas M.D. Anderson Cancer Center, Houston, USA )
11 Feb 2015

mRCC: Understanding the patient's perspective

Dr David Cella - Northwestern University, Chicago, USA
mRCC: Understanding the patient's perspective ( Dr David Cella - Northwestern University, Chicago, USA )
11 Feb 2015

mRCC: Closing remarks

Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France
mRCC: Closing remarks ( Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France )
11 Feb 2015